Feb 25, 2026 07:59AM
Feb 25, 2026 07:59AM
Jan 20, 2026 05:20PM
Nov 26, 2025 04:05PM
Nov 26, 2025 04:05PM
Nov 25, 2025 08:00AM
Nov 25, 2025 08:00AM Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
Nov 5, 2025 08:30AM
Sep 8, 2025 07:01AM
Aug 11, 2025 04:12PM
Jul 28, 2025 07:00AM
Jun 30, 2025 08:10AM
Jun 30, 2025 08:00AM
Jun 11, 2025 08:01AM Tempest Therapeutics (TPST) Announces 739K Share offering at $6.25/sh
Jun 11, 2025 08:00AM
Jun 5, 2025 10:28AM
Jun 5, 2025 08:00AM
May 13, 2025 04:28PM
Apr 28, 2025 04:05PM
Apr 21, 2025 08:01AM
Apr 21, 2025 08:00AM Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
Apr 10, 2025 06:02AM
Apr 9, 2025 04:30PM
Apr 9, 2025 04:30PM
Mar 28, 2025 06:47AM
Mar 27, 2025 04:10PM
Mar 25, 2025 04:30PM
Mar 13, 2025 08:00AM Tempest Therapeutics (TPST) Receives FDA Study May Proceed Notice for Phase 2 Trial of TPST-1495
Mar 13, 2025 08:00AM
Feb 10, 2025 08:00AM
Feb 10, 2025 08:00AM
Feb 7, 2025 04:30PM
Jan 6, 2025 08:03AM
Jan 6, 2025 08:00AM
Dec 6, 2024 04:30PM Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 25, 2024 04:30PM
Nov 13, 2024 09:30AM
Nov 12, 2024 04:21PM
Nov 12, 2024 08:01AM
Nov 12, 2024 08:00AM
Oct 11, 2024 06:39AM
Oct 10, 2024 07:01AM Tempest Therapeutics (TPST) Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Trial
Oct 10, 2024 07:01AM
Oct 10, 2024 07:00AM
Sep 20, 2024 04:30PM
Sep 18, 2024 08:00AM
Sep 5, 2024 08:00AM
Aug 23, 2024 04:30PM
Aug 21, 2024 08:02AM Tempest Therapeutics (TPST) Appoints Troy M. Wagner as VP of Quality Assurance
Aug 21, 2024 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All